Introduction
Cefadroxil, the para-hydroxy analog of cephalexin, is a new oral semisynthetic cephalosporin possessing antimicrobial activity against most strains of Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Klebsiella species, and penicillin-sensitive and -resistant Staphylococcus aureus (3) . Below are results of absorption and excretion studies of cefadroxil and cephalexin in human volunteers. In addition, in vitro data of antibacterial activity of the two drugs are presented.
Materials and Methods
Absorption and excretion. Studies were performed on 20 healthy adult male volunteers. Participants were 23 to 44 years old, and weights ranged from 63 to 100 kg, with a mean of 79 kg. All volunteers were ambulatory during the study and had not received an antibiotic within 3 weeks prior to participation. Informed consent was obtained from all participants. A balanced, incomplete block design (15) was used to study the following treatment regimens (eight courses each): (I) eefadroxil, 500 mg orally (p. o.) in a single dose; (II) cephalexin, 500 mg p. o. in a single dose; (III) cefadroxil, 1000 mg p. o, in a single dose; (IV) cefadroxil, 500 rag/dose p. o. every 6 h for four times; and (V) cephalexin, 500 rag/dose p. o. every 6 h for four times. Each subject received two of the above regimens by a table of randomization. Seven days elapsed between the periods of study. Each subject fasted overnight prior to ingestion of the first drug dose, and no food was eaten from 1 h before to 2 h after subsequent drug ingestion. Liquids and food were not otherwise restricted or limited. Blood samples were obtained before the first drug dosage and thereafter as indicated: single dose -0.5, 1,1.5, 2, 4, 6 and 12 h; every-6-h doses -0.5, 1, 2, 6, 7, 8, 12, 13, 14, 18, 19, 20 , and 24 h. Blood was placed at 4 ° C, and serum was separated and stored at -20 ° C until assayed. Urine was obtained 0 to 3, 3 to 6, 6 to 12, 12 to 18, and 18 to 24 h after initiation of the study. Collections during these periods were stored at 4 ° C through the end of each interval, at which time a total volume was determined, and a portion was stored at -20 ° C until assayed. Untoward side-effects were recorded after each study period. Urine analyses, complete blood counts, and measurements of serum glutamic oxaloacetic transaminase, creatinine, urea nitrogen, fasting sugar, alkaline phosphatase, acid phosphatase, and calcium were carried out prior to and 2 days after each study period. Antibiotic assay. Antibiotic concentrations in serum and urine were measured by a modification of the agar-well diffusion assay technique described by Bennett et al. (2) . Antibiotic assay agar number one was used as the assay media, with spores of Bacillus subtilis (Difco) as the indicator organism. Stock solutions of cefadroxil and cephalexin containing 1000 ~xg/ml were ~tored at -20 ~ C. Stocks were diluted on each test day to give standard concentrations ranging from 50 to 0.78 ~g/ml. Diluents were pooled normal human serum for the serum standards and phosphate-buffered saline (pH 7.4) for the urine standards. Uririe samples were diluted with phosphate-buffered saline as necessary. All assays were performed in triplicate.
Test organisms. The test organisms included 20 strains of S. aureus, Staphylococcus epidermidis, E. coli, and Klebsiella species and 18 strains of S. pneumoniae. All organisms were isolated from blood cultures. S. pneumoniae were stored in serum and Trypticase soy broth at -70 ° C. Other bacteria were maintained on nutrient agar slants at room temperature.
Susceptibility test methods. Cefadroxil was provided by Mead
Johnson Research Center, Evansville, Ind., and cephalexin was obtained from Eli Lilly & Co., Indianapolis, Ind. Antibiotic standard reference powders were stored at -20 ° C. Stock solutions of 2.048 txg/ml in sterile distilled water were freshly prepared on each test day and serially diluted in the appropriate culture medium. After addition of the inocutum, the final concentrations were 512 to 1 Ixg/ml for gram-negative organisms, 256 to 0.5 Ixg/ml for staphylococci, and t28 to 0.25 Ixg/ml for S.
pneumoniae.
Minimal inhibitory concentration (MIC) values were determined with Mueller-Hinton broth (Todd-Hewitt broth for pneumococci) by the international collaborative study protocol (5). Inocula were prepared by diluting 4 to 6 h broth cultures of the organisms with saline to the equivalent optical density of one-half that of a number 1 McFarland standard (7) and then diluting 1:2000 with broth. These inocula were added to the antibiotic dilutions, and tubes were incubated aerobically at 37 ° C for 18 h. The most dilute antibiotic concentration resulting in no visible turbidity was recorded as the MIC. A portion (0.1 ml) from each tube without turbidity was inoculated into blood agar and incubated aerobically (pneumococci in 5 to 10% CO2) at 37 ° C for 18 h. Colony counts were performed, and the lowest antibiotic concentration yielding -< 0.1% survival was recorded as the minimal bactericidal concentration (MBC).
Controls.
Tubes containing only broth and inoculum and broth alone acted as positive and negative controls, respectively. MIC and MBC determinations were made in parallel with test bacteria, using standard S. aureus (ATCC 25923) and E. coil (ATCC 25922).
Results

Absorption and excretion: (I) Single-dose treatment.
Concentrations of the antibiotics in serum are shown in Fig. 1 . The concentration of cephalexin was maximum at 1 h, and the peak concentration of cefadroxil occurred at t.5 h. Cephalexin concentration in serum declined more rapidly than cefadroxil. At 6 h after ingestion, the cefadroxil concentration was approximately equal to the calculated concentration of cephalexin present at 3.5 h postingestion. Furthermore, cephalexin was not measurable in serum at 6 h. Seventy percent of the dose of cephalexin was eliminated in the urine within 3 h (Table 1) ; 58% of the cefadroxil was eliminated in the same time period. At 12 h, the majority of both drugs had been. excreted. However, during the 6-to 12-13 time period, threefold more cefadroxil than cephalexin was eliminated, yielding a threefold higher antibiotic concentration in urine. At 24 h, 93% of the cefadroxil and 85% of the cephalexin had been excreted. Since urine collections were complete in all study subjects, it must be assumed that the remaining proportions of the ingested doses were either not absorbed or metabolized to a less active form. (III) Multiple-dose treatment. Levels in serum after ingestion of 500 mg every 6 h of both drugs are shown in Fig. 2 . Levels of the antibiotics in serum were similar to those obtained after the single-dose trials, and accumulation of either drug in serum was not observed. There were slight increases in mean concentrations 6 h after each successive dose (except that after the last cefadroxil dose), but the differences were small. Individual variations in concentration were marked, particularly those at 1 to 2 h after drug ingestion. With the third and fourth doses, cephalexin concentrations were maximum at 2 h after ingestion, rather than at 1 h as demonstrated with the first two doses. Mean concentrations of cefadroxil in serum were consistently greater than cephalexin at 2 to 6 h after each dose. When given every 6 h, both drugs maintained high and equivalent concentrations in urine (> 500 jxg/ml) throughout the treatment period.
Toxicity and side-effects. All patients tolerated the medications well. None developed symptoms or abnormal laboratory studies suggestive of drug toxicity.
Antimicrobial activity. In vitro antimicrobial activities of cephalexin and cefadroxil for the test organisms are shown in Table 2 . Except for minor variations, the MIC and MBC of the antibiotics for the bacteria studied were achieveable in serum after oral 500 mg doses of drugs. In contrast to the other test bacteria, S. aureus and E. coli required greater than a twofold higher drug concentration to achieve bactericidal activity than inhibitory activity.
Discussion
The present study suggests that cefadroxil, a new oral cephalosporin antibiotic, compares favorably with cephalexin. After equivalent oral dosages, concentrations of cefadroxil in serum were higher and more sustained than were those of cephalexin after 1.5 h post ingestion. In parallel with these observations, cefadroxil concentrations in urine were also more sustained. Similar results were reported by Pfeffer et al. (9) . Except for minor differences, the MIC and MBC values of the two drugs against clinical isolates of S. pneumoniae, S. aureus, S. epidermidis, E~ coli, and Ktebsiella species were similar. Excluding S. epidermidis, most organisms were inhibited by concentrations of antibiotics that could be achieved in serum with oral administration. Buck and Price have reported similar results (3). In addition to these observations, the cefadroxil concentration in urine was maintained well above the MIC of all organisms tested (except for the unusual resistant S. epidermidis isolates) for 12 h and, in most instances, for 18 h. In contrast, 6 h after ingestion, the cephalexin concentration in urine was relatively low. Numerous studies have shown that effective antimicrobial activity in urine is most important in curing urinary tract infections (6, 11, 12) . Furthermore, the study of Landes (6) Although not previously shown for E. coli, these large differences in the antibiotic concentrations necessary to produce a bactericidal effect compared with an inhibitory effect have been demonstrated with many cephalosporins when staphylococci are used as test organism (1, t0, 13) . The reason for this phenomenon is not clear, but it may be dependent, in part, on inoculum size (13) . The clinical significance of this finding is unknown, but it may be worthy of consideration when selecting an antibiotic for treatment of an infection for which bactericidal concentrations in serum may be critical, such as endocarditis (14) .
